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The need for psychological therapies for psychosis is
increasingly acknowledged. There are a number of reasons
for this. First, while antipsychotic medication has been the
mainstay of psychiatric treatment and shows considerable
benefits, it does not guarantee good outcome, being only
partially effective or minimally effective in approximately
40% of cases (1). Secondly, adherence to antipsychotic
medication is frequently poor, with up to 70% of individu-
als failing to take medication as prescribed (2). Thirdly, even
when long-term antipsychotic medication is taken, a sub-
stantial proportion of patients will relapse (approximately
20% in one year) (3), the probability of which will be influ-
enced by the social context, such as the nature of the fami-
ly environment or the experience of life events (4). Finally,
although medication may improve certain symptoms, it typ-
ically does not impact on a wide range of individuals’ other
concerns about their illness or experiences and often fails to
remediate a number of other disabling problems, particu-
larly of a social or cognitive nature.
In recent years, two psychological treatment approaches
have particularly emerged as potentially effective therapies to
be considered in the treatment of people with schizophrenia:
‘family interventions’ (FI) and cognitive behavioural therapy
(CBT) (5). Two other approaches have been the focus of
research activity, particularly in the United States: social skills
training and cognitive remediation. The evidence derived
from randomised controlled trials for these four approaches
has recently been systematically reviewed, using meta-analyt-
ic techniques (6,7). In the UK, an evidence-based treatment
guideline for schizophrenia has also just been developed,
which reviews the evidence for these four psychological treat-
ments together with three other distinct psychological
approaches: psychoeducation, psychoanalytic or psychody-
namic therapies and  supportive counselling (8). When exam-
ined together, the evidence clearly indicates that CBT and FI
have the strongest evidence base for effectiveness (5-8). In
this paper, CBT and FI will be described and discussed; inter-
ested readers are referred to the foregoing references for
detailed evaluations of the other approaches.
The rationale for psychological treatment approaches for
psychosis does not only derive from the limitations of med-
ication. Current conceptualisations of psychosis, within a
stress-vulnerability framework (9), offer a positive rationale
for their action (10). Here, psychosis is viewed as multi-facto-
rial, and results from an interaction of a predisposing vulner-
ability (of biopsychosocial origin) with environmental stres-
sors. The vulnerability factors include emotional difficulties,
such as low self-esteem and social anxiety, cognitive biases or
deficits, and biological factors of genetic and neuro-develop-
mental origin (11). The stressors, such as stressful life events,
hostile environments, psychoactive drugs or prolonged social
isolation, affect both the cognitive and emotional processes of
the vulnerable individual, causing changes such as anxiety or
depression, and information processing difficulties and result-
ing anomalous experiences (e.g. hallucinatory experiences).
These changes are disturbing and are actively interpreted by
the individual; the resulting interpretations of the meaning of
these changes to the self and of the triggering events lead to
the fully formed psychotic symptoms. Similar processes then
maintain the psychosis and, in addition, the experience and
consequences of psychosis itself and its treatment may pro-
vide further maintaining factors, such as a reluctance to take
medication or depressed mood and hopelessness. 
It will be apparent how psychological therapies, whether
aimed at the individual’s ways of interpreting events and/or
experiences and resulting beliefs and emotions (CBT), or at
improving the atmosphere and coping of the family mem-
bers (FI), are suited to addressing stress and vulnerability
factors and may therefore be beneficial in the treatment of
the psychosis. In this paper, I will describe CBT and FI
approaches, discuss the current evidence for them and con-
sider key future directions for psychological therapies.
The future of psychological therapies for psychosis
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THERAPEUTIC APPROACHES
Cognitive behavioural therapy
CBT for psychosis, which has been developed largely
in the UK over the past decade, draws on two main
sources: stress-vulnerability models of psychosis, as dis-
cussed above, and cognitive theory and therapy for emo-
tional disorders (e.g. 12). CBT takes as its central focus
the experiences of psychosis, that is, the symptoms and
the individual’s attempts to understand them. The main
goal will be to help the individual to arrive at an under-
standing of the psychosis which is less distressing, and
assist the individual in preventing reoccurrence or in
managing any unwanted experiences and in developing
as full and satisfying a life as possible (13).
The thoughts, beliefs and images experienced by people
are the core material with which therapists work (14). The
approach draws extensively on the cognitive therapy of Beck
and colleagues, both in content and style. In style, the
approach is collaborative and enquiring, aiming to work
with the individual towards a new shared understanding.
The content of therapy involves identifying key beliefs and
thoughts, and reviewing evidence for these beliefs, identify-
ing thinking biases and relating thoughts to mood and
behaviour. The person with psychosis will be encouraged to
try out new ways of behaving or thinking in ‘homework’
exercises between sessions. However, the standard cognitive
therapy approach is modified to take account of the partic-
ular needs of people with psychosis and to be tailored to the
cognitive model of psychosis and the stress-vulnerability
framework. Modifications include taking longer over the
early stages of therapy, so as to engage people who may be
very suspicious or experience cognitive difficulties, and flex-
ibility about session timing and length, to ensure that thera-
py sessions are not experienced as excessively stressful.  
CBT for psychosis is delivered as a structured and time-
limited therapy, although with considerable flexibility.
Most studies have provided an average of about twenty
sessions offered weekly to fortnightly over nine months,
ranging from ten to thirty sessions over three months to
two years. CBT is delivered alongside other services and
medication, and is ideally integrated with the whole pack-
age of care, although it can be offered to people who do
not engage in services or take medication.  More detailed
descriptions of the therapy are available (13,14).
Family interventions
FI also draw explicitly on the stress-vulnerability model
of psychosis. The approach derives from the pioneering
work of Brown, Leff and Vaughn in identifying the role of
aspects of the emotional atmosphere in the family (criti-
cism, hostility and emotional involvement - collectively
termed ‘expressed emotion’, EE) in contributing to relapse
(15). The first FI studies were published in the early 1980s
(16,17) and the approach has been disseminated across
the world in the twenty years since. FI have been primari-
ly aimed at reducing the risk of relapse in a vulnerable
individual, by altering one possible source of stress - the
emotional climate of the family environment. It should be
noted that, in this context, ‘family’ includes people who
have a significant emotional connection with the person
with psychosis, such as parents, siblings and partners.
This FI approach is described in detail by Kuipers and
colleagues, who specify five basic assumptions (18):
1. Schizophrenia is seen as an illness with a biological
origin within a stress-vulnerability model. Stresses
might bring on the illness or relapse.
2. Families are seen as invaluable allies in care, and the
formation of a therapeutic alliance with the family is
seen as essential. Families are not blamed but enlist-
ed as therapeutic agents, in order to help the patients.
3. There is an emphasis on collaboration and openness.
Information about the illness is discussed, and
together therapists and family members, including
the patient, agree goals, priorities and tasks.
4. Families are seen to have needs and strengths.
5. The FI approach is offered alongside other interven-
tions, including medication. 
Overall, the aim of FI is to improve the family atmos-
phere and to reduce relapse. It typically involves a number
of components. These are: the provision of information
about psychosis (sometimes called ‘psychoeducation’),
improving coping with the affected member’s psychosis by
identifying problems and agreeing solutions, and helping
the family members to communicate in a positive fashion
and to set appropriate boundaries within the family. There
is some variety in the way FI are provided (6). Some FI
aim explicitly also to reduce the distress felt by the carers,
rather than keeping a main focus on just the patient’s out-
comes. In such cases families may be seen without the
identified patient present or in groups of relatives. Some
FI involve very explicit communication or skills training,
and, more rarely, some employ systemic or psychodynam-
ic principles or methods. There is also considerable vari-
ability in the duration and frequency with which FI are
delivered. Typically, FI are offered for about one year,
although this may range from a few months to three years,
with sessions fortnightly to monthly. Two therapists will
generally be present in family sessions.
EVIDENCE OF EFFECTIVENESS
Cognitive behavioural therapy
Randomised controlled trials of CBT were first report-
ed in the early 1990s and the research evidence base is
small but developing rapidly. Pilling et al (6) report a meta-
analysis of eight randomised controlled trials. When this
review was updated by the UK National Schizophrenia
Guideline Group, recent publication of new trials enabled
a total of thirteen trials to be reviewed, including data on
a total of 1293 patients (8). All the patients in these trials
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were prescribed antipsychotic medication and most of the
trials were targeted at individuals with long-standing or
medication-unresponsive symptoms. Most of the studies
(10) were conducted in the UK, while two were from the
USA and one was from Israel.
Symptoms
The Schizophrenia Guideline review found that CBT
reduces symptoms, both during treatment and at 9-12
month follow-up. This finding applied both when CBT
was compared with treatment as usual and when com-
pared to other psychological interventions, such as sup-
portive counselling. 
Relapse and suicide
There was insufficient evidence to determine whether
CBT reduced suicide, with very low numbers of suicide in
total reported. There was also insufficient evidence to
determine whether CBT reduces relapse; however, there
was evidence that CBT of longer duration (more than 3
months) is effective at reducing relapse.
Other outcomes
CBT was found to improve ‘medication adherence’ and
improve insight. There was some evidence for improve-
ments in social functioning. 
Methods of delivery
Some evidence was found that CBT of longer duration
(6-12 months rather than less than three months) and/or
of more sessions (at least ten planned sessions) was more
effective in symptom reduction. The reviewers also noted
that the evidence was stronger for the treatment of people
with persisting symptoms than for short treatments in the
acute phase of the first episode of schizophrenia. 
Family interventions
Pilling et al (6) also report a meta-analysis of the out-
come data from 18 randomised controlled trials of FI,
which involved a total of 1467 patients with a diagnosis of
schizophrenia. Studies were conducted in a wide range of
countries, dating back two decades. The mean age of the
patients included was 31.2 years, 31% of the patients were
women, and the mean number of admissions, reported in
13 of the trials, was 2.7. There were a number of different
outcomes targeted by the FI and reported in the studies.
Pilling et al report on relapse, readmission, suicide, family
outcomes and adherence to medication regimes. This
review was also used as the basis for the UK National
Schizophrenia Guideline, whose authors updated and
conducted some additional analyses of the data (8). 
Relapse and readmission
It was found that there is strong evidence that FI reduce
relapse rates during the treatment and at follow-up, up to 15
months after the FI ended. They are also effective at reduc-
ing admission to hospital during treatment, although not
when the FI had ended. There is also evidence that FI are
effective in reducing relapse both for people who have per-
sisting symptoms and for those who have recently relapsed. 
Other outcomes
There were no differences in suicide rates between FI
and control treatments. There was evidence that medica-
tion adherence is increased by FI and that the family mem-
bers’ ‘burden of care’ was decreased by FI, when these
were delivered to single families rather than groups of fam-
ilies. There was insufficient evidence to indicate whether
FI reduce psychotic symptoms; many studies did not
report any symptom data.
Methods of delivery
The Schizophrenia Guideline (8) reports on analyses of
different methods of delivery. Stronger evidence was
found for relapse prevention with programmes of longer
duration (6 months or longer) and a greater number of ses-
sions (ten or more planned sessions). The evidence was
also stronger for relapse prevention when the service user
was included in the sessions.
Summary of evidence
These systematic reviews have demonstrated that both
CBT and FI, under the conditions of research trials, are
effective for certain key outcomes. Consistent with the
stated key goals of these approaches, CBT reduces symp-
toms and FI reduce rates of relapse. Both approaches also
show some evidence of benefits for certain other out-
comes under certain conditions - CBT for insight, relapse,
medication adherence and social functioning, and FI for
medication adherence and relatives’ ‘burden of care’. The
evidence concerning CBT is overwhelmingly UK based
and predominantly relates to people with persisting symp-
toms, while the FI evidence base is more international and
is drawn mainly from relapsing and persisting symptom
groups. There is a great deal that is yet to be investigated.
It is to the future of these psychological approaches that I
now turn.
FUTURE DIRECTIONS
Early intervention
The evidence reviewed here raises further questions.
First, there is the question of which patients are helped by
these methods. Globally, there is currently considerable
interest in the early identification and treatment of people
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with psychosis. Stimulated by the pioneering work of
McGorry and colleagues in Melbourne, Australia, a
worldwide movement has developed for the establishment
of services for early psychosis (19). This constitutes two
elements - the early identification and (possible) treatment
of people at high risk of developing psychosis, and the
early identification and treatment of people who have a
diagnosable psychosis. Interventions with ‘high risk’
groups, identified by being a first degree relative of a per-
son with psychosis and/or the presence of prodromal
symptoms or brief psychotic symptoms (20) are currently
research based. A number of trials of CBT to prevent tran-
sition to psychosis, with or without low dose antipsychot-
ic medication, are underway (21-23). The early reports
suggest that a CBT intervention, alone or in combination
with medication, may delay or prevent transition to psy-
chosis in a proportion of people. 
In the UK, the comprehensive first episode services
which are being set up frequently incorporate psychologi-
cal approaches, most commonly CBT and FI, alongside
medication, and other psychosocial approaches, such as
vocational and social programmes (24,25). It is not yet
clear what the place of CBT and FI in such services should
be. For example, should either or both psychological
approaches be routinely offered to all or should they be tar-
geted at certain groups, such as those with persistent symp-
toms or relapses? The evaluation of these specialised ser-
vices for early psychosis is at an early stage, with no ran-
domised controlled trial of an integrated comprehensive
first episode service yet published, and teasing apart the
different treatment components will prove difficult. There
have, however, been a very small number of published tri-
als (and even fewer randomised controlled trials) of  CBT
or FI in early psychosis in the context of more standard
inpatient or community services. Those that have been
published concerning first episode treatments have not yet
yielded very strong positive findings. Two studies of a CBT
approach, one focussed on the acute inpatient stay (26)
and the other on community follow-up, where only some
participants received specialised first episode services (27),
show only modest and temporary benefits. However, we
do have some data from a pilot study of CBT and FI for
first episode patients in an adolescent inpatient unit, which
suggests clear benefits in terms of symptom reductions
from CBT and social functioning improvements with FI
(28). Another study, which combined an individual psy-
chosocial approach with FI, in both the inpatient and the
community follow-up phases of care, did not find clear
benefits of relapse reduction from the FI (29). One possible
reason for the failure to find a specific benefit for the psy-
chological intervention in these studies is that a high pro-
portion of these first episode participants are improving
considerably with medication and other interventions, and
thus the additional benefits of specific psychological inter-
ventions are relatively small or subtle and difficult to
detect; alternatively, they may not confer additional benefit
at this stage for most and, as a scarce resource, should be
targeted at sub-groups with specific needs. However, we
are at the early stages of this research effort and more evi-
dence will help to determine the place of psychological
interventions with this first episode group. 
Relapse prevention
A second group to consider is those who experience
repeated relapse. This is in contrast to the people with rel-
atively stable persisting symptoms who have been includ-
ed in many CBT and FI studies; the evidence suggests
these patients with persisting symptoms are helped by
both approaches, but with different outcomes - reducing
symptoms and relapse, respectively. People at high risk of
relapse have been selected for FI studies, but no CBT stud-
ies have yet been published with this group. However,
Gumley et al (30) report one such study and demonstrate
significant reductions in relapses with a CBT intervention
designed for this purpose. This, together with the system-
atic review evidence suggesting relapse reduction benefits
with CBT (8), raises the question as to the relative merits
of FI and CBT in reducing relapse. 
Other groups and targets for intervention
There are a number of other sub-groups of people with
psychosis for whom psychological therapies may be bene-
ficial. A variety of promising new applications of these
therapies are being developed. Barrowclough et al (31)
have shown benefits for the important group of people
with ‘dual diagnosis’ (co-existing substance misuse and
psychosis) from a combined motivational interviewing,
CBT and FI approach. In contrast to a focus on particular
sub-groups, some CBT approaches have been successfully
targeted on certain specific outcomes. For example,
Mueser et al (32) have documented high rates of trauma
and post-traumatic stress disorder (PTSD) in people with
psychosis. They have subsequently piloted a modified
CBT approach for PTSD symptoms in people with psy-
chosis, which was demonstrated to be feasible and prom-
ising. Other specific targets for which CBT has been
shown beneficial include medication adherence (33) and
insight (34).  One further aspect which is under develop-
ment is the treatment of low self esteem and depression in
psychosis (28,35,36). In this rapidly developing field, we
can expect new findings over the next five to ten years,
from treatment studies and from theoretical and empirical
research into aspects of psychosis, which will offer an
impetus for the further refinement of CBT and FI.  
Training and dissemination
In general, CBT and FI were originally developed by
qualified clinical psychologists and psychiatrists, often
with considerable experience of clinical practice, therapy
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and research in psychosis. In the research trials which have
established efficacy, interventions have followed therapeu-
tic manuals and supervision has typically been intensive.
As these approaches have been disseminated more widely,
other mental health professionals, with a variety of training
backgrounds, have taken on this work. Formal training
courses have been developed in some countries, although
there is not as yet a clear consensus on required training.
Furthermore, there is evidence that training alone may not
be sufficient to ensure effective implementation (37). In
consequence, Tarrier has argued that the organisation and
management of training and services need to be planned
and evaluated to ensure that staff are adequately skilled to
offer systematic therapeutic interventions.  It is also impor-
tant to ensure that they have time to see patients regularly
and receive skilled supervision.
While CBT for psychosis is a relatively new approach,
only recently expanding beyond the confines of research
settings, FI have been established as effective for over a
decade, and services in many countries have attempted to
disseminate the FI approach into routine practice. There
has been considerable difficulty with this, at least in UK
(38). In addition to the practical difficulties of delivering
interventions with a family group, as opposed to individu-
als, another reason for this may be the changing nature of
family structures in some countries. In urban settings in
Northern European countries, there is growing evidence
of fragmentation of family ties and higher levels of separa-
tion and isolation. In one multi-centre European study of
the care of people with serious mental illness, between
two thirds and one half of the patients in the Northern
European centres lived alone (39). FI can be conducted
with family members not living together, if in close con-
tact, but may not be applicable when contact and care-giv-
ing is less. For these reasons, in certain cultures, individ-
ual therapies such as CBT may be more practicable in
many cases.   
CONCLUSIONS
The current evidence confirms that FI are effective at
reducing relapse in psychosis and that CBT is effective for
symptom reduction. A variety of other benefits and new
applications are suggested by current research, and thus
both approaches are likely to play leading roles as psy-
chotherapies for psychosis in the future. There are many
potential areas for development, most notably, perhaps, in
the treatment of co-existing substance misuse and in the
growing field of early intervention. However, other targets
for these approaches should not be neglected, such as
relapse prevention or the treatment of depression and
trauma. There is no suggestion, in most of their applica-
tions (except perhaps with ‘high risk’ groups - see 40), that
these psychological therapies will stand alone. There are a
number of other important therapeutic elements, medica-
tion certainly, but also the provision of a range of social
activity, leisure and work programmes. It is likely that CBT
and FI will best meet the wider goals of improving out-
comes for patients, in ways which are accessible and
acceptable, when they are effectively integrated within
comprehensive services. 
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